Prof. Sina Dorudi, Consultant Colorectal Surgeon
Prof. Sina Dorudi
Consultant Colorectal Surgeon
Prof. Sina Dorudi BSc, MBBS, PhD, FRCS, FRCS (Gen)
Consultant Colorectal Surgeon
Prof. Sina Dorudi
Consultant Colorectal Surgeon BSc, MBBS, PhD, FRCS, FRCS (Gen)
Recommendations for Prof. Dorudi
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
Make an appointment
Address
-
Mayo Clinic Healthcare
15 Portland Place, London, W1B 1PT
-
The Princess Grace Hospital
42-52 Nottingham Place, London, W1U 5NY
-
London Digestive Centre
41 Welbeck Street, London, W1G 8EA
About Prof. Sina Dorudi
GMC number: 2822916
Year qualified: 1983
Place of primary qualification: University of London
Prof. Sina Dorudi is a consultant colorectal surgeon and the medical director at Mayo Clinic Healthcare in London. He has extensive experience in leading best practice clinics and is dedicated to all aspects of colorectal and general surgery. Previously, he served as a consultant colorectal surgeon at St Bartholomew's and The Royal London Hospitals in London, where he was the lead colorectal cancer surgeon and later became Professor of Surgical Oncology. Now in private practice, Prof. Dorudi was formerly the medical director at The (HCA) Princess Grace Hospital before assuming the same role at Mayo Clinic Healthcare in October 2023.
Prof. Dorudi treats a wide range of conditions, including abdominal and groin hernias, abdominal pain, anal fissures, anal fistulas, bowel cancer, changes in bowel habits, Crohn's disease, haemorrhoids, rectal bleeding, and ulcerative colitis. His procedural expertise includes colonoscopy and bowel cancer screening, as well as various colorectal surgeries, with a particular focus on gastroenterology and digestive diseases.
Educated and trained in London, Prof. Dorudi qualified from medical school and further honed his skills in general and colorectal surgery in Oxford and London. He completed a specialty fellowship in colorectal surgery in Sydney, Australia. His qualifications are exemplary, including a BSc (Hons) First Class Honours, MBBS from Imperial College, FRCS from the Royal College of Surgeons of England, a PhD from the University of London, and the FRCS (Gen) Award of Completion Certificate in Specialist Training.
In the realm of research, Prof. Dorudi's work has significantly contributed to improving the prognostic stratification of colorectal cancer patients post-surgery and exploring the immunology of various colorectal cancer phenotypes. His current research focuses on developing tools to measure and optimise outcomes for patients who have undergone major abdominal surgery. He is actively involved in supervising a trainee surgeon pursuing a PhD in this field.
Prof. Dorudi is a Fellow of the Royal College of Surgeons and the Royal Society of Medicine, and a member of the Association of Coloproctology of Great Britain & Ireland. He is proficient in English and has conversational skills in Farsi.
Areas of expertise
- Abdominal and groin hernias
- Abdominal pain
- All aspects of colorectal surgery (open and laparoscopic)
- Anal cancer
- Anal fissure
- Anal fistula
- Bowel cancer
- Change in bowel habit
- Colon cancer
- Colonoscopy and bowel cancer screening
- Colorectal disease
- Colorectal surgery
- Crohn's disease
- Fistulas/pilonidal sinus (including laser treatment)
- Flexible sigmoidoscopy
- Gastroenterology (digestive diseases)
- Gastroscopy
- Gastroscopy OGD
- General surgery (particularly abdominal wall and groin hernia)
- Haemorrhoids ('piles')
- Hernia repair (keyhole)
- Inguinal hernia
- Laparoscopic procedures ('keyhole surgery')
- Laparoscopy
- Open hernia repair
- Rectal bleeding
- Rectal cancer
- Ulcerative colitis
Professional memberships
Articles by Prof. Sina Dorudi
Banerjea A, Ahmed S, Hands RE, Huang F, Han X, Shaw PM, Feakins R, Bustin SA, Dorudi SColorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity. Mol Cancer 3: 21
Rapid adenoviral transduction of freshly resected tumour explants with therapeutically useful genes provides a rationale for genetic immunotherapy for colorectal cancer
Dorudi S, Hanby AM, Poulsom R, Northover J, Hart IRLevel of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer 71: 614-616
Analysis of colorectal cancers in british bangladeshi identifies early onset, frequent mucinous histotype and a high prevalence of rbfox1 deletion
Detection of cytokeratins 19/20 and guanylyl cyclase c in peripheral blood of colorectal cancer patients
Immunogenic hsp-70 is overexpressed in colorectal cancers with high-degree microsatellite instability